| Mary A Kovalak, MD | |
|
499 E Hampden Ave Ste 420, Englewood, CO 80113-2794 | |
| (303) 788-8888 | |
| (866) 896-1158 |
| Full Name | Mary A Kovalak |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 22 Years |
| Location | 499 E Hampden Ave Ste 420, Englewood, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003861030 | NPI | - | NPPES |
| 78529760 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 48189 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Littleton Adventist Hospital, Centura Health | Littleton, CO | Hospital |
| Rose Medical Center | Denver, CO | Hospital |
| Hca-healthone Dba Swedish Medical Center | Englewood, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Denver Gastroenterology, P.c | 2062302508 | 47 |
News Archive
A study published in Nature Genetics today has found new evidence for a link between the body clock hormone melatonin and type 2 diabetes. The study found that people who carry rare genetic mutations in the receptor for melatonin have a much higher risk of type 2 diabetes.
"South Sudan's army on Wednesday appealed for concerted efforts to fight against HIV/AIDS, stressing that the war against the sexually transmitted disease cannot be fought by one institution or group of some officials tasked by the government," the Sudan Tribune reports.
Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.
VBI Vaccines (VBI), a biotechnology company dedicated to the innovative formulation, development and delivery of safe and effective vaccines, announced today that it has completed the acquisition of Epixis S.A., a French biotechnology company developing its "eVLP" platform technology for a new generation of Virus-Like Particle (VLP) vaccines.
› Verified 6 days ago
| Entity Name | South Denver Gastroenterology, P.c |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447364831 PECOS PAC ID: 2062302508 Enrollment ID: O20040317001558 |
News Archive
A study published in Nature Genetics today has found new evidence for a link between the body clock hormone melatonin and type 2 diabetes. The study found that people who carry rare genetic mutations in the receptor for melatonin have a much higher risk of type 2 diabetes.
"South Sudan's army on Wednesday appealed for concerted efforts to fight against HIV/AIDS, stressing that the war against the sexually transmitted disease cannot be fought by one institution or group of some officials tasked by the government," the Sudan Tribune reports.
Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.
VBI Vaccines (VBI), a biotechnology company dedicated to the innovative formulation, development and delivery of safe and effective vaccines, announced today that it has completed the acquisition of Epixis S.A., a French biotechnology company developing its "eVLP" platform technology for a new generation of Virus-Like Particle (VLP) vaccines.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary A Kovalak, MD 499 E Hampden Ave Ste 420, Englewood, CO 80113-2794 Ph: (303) 788-8888 | Mary A Kovalak, MD 499 E Hampden Ave Ste 420, Englewood, CO 80113-2794 Ph: (303) 788-8888 |
News Archive
A study published in Nature Genetics today has found new evidence for a link between the body clock hormone melatonin and type 2 diabetes. The study found that people who carry rare genetic mutations in the receptor for melatonin have a much higher risk of type 2 diabetes.
"South Sudan's army on Wednesday appealed for concerted efforts to fight against HIV/AIDS, stressing that the war against the sexually transmitted disease cannot be fought by one institution or group of some officials tasked by the government," the Sudan Tribune reports.
Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.
VBI Vaccines (VBI), a biotechnology company dedicated to the innovative formulation, development and delivery of safe and effective vaccines, announced today that it has completed the acquisition of Epixis S.A., a French biotechnology company developing its "eVLP" platform technology for a new generation of Virus-Like Particle (VLP) vaccines.
› Verified 6 days ago
Kathleen M Carlson, RN Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2955 S Broadway, Englewood, CO 80113 Phone: 303-788-1118 | |
Scott Press, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 372 Inverness Dr South, Englewood, CO 80112 Phone: 720-741-8800 | |
Samir Ezzeldin Witta, MD PHD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3501 S Corona St Ste 1, Englewood, CO 80113 Phone: 303-999-6745 Fax: 303-586-2228 | |
Jennifer L Loucks, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 701 E Hampden Ave, Ste 410, Englewood, CO 80113 Phone: 303-788-1312 Fax: 303-788-1967 | |
Christopher Mark Courtney, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 601 E Hampden Ave, #160, Englewood, CO 80113 Phone: 303-788-7430 Fax: 303-788-7437 | |
Marina Vladimirovna Bachurina, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 501 E. Hampden Ave., Englewood, CO 80113 Phone: 303-788-6911 Fax: 303-306-7753 |